DK0746332T3 - DNA, som koder for en human neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelse deraf - Google Patents
DNA, som koder for en human neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelse derafInfo
- Publication number
- DK0746332T3 DK0746332T3 DK95907215T DK95907215T DK0746332T3 DK 0746332 T3 DK0746332 T3 DK 0746332T3 DK 95907215 T DK95907215 T DK 95907215T DK 95907215 T DK95907215 T DK 95907215T DK 0746332 T3 DK0746332 T3 DK 0746332T3
- Authority
- DK
- Denmark
- Prior art keywords
- human
- receptor
- nucleic acid
- acid molecule
- dna encoding
- Prior art date
Links
- YNXLOPYTAAFMTN-SBUIBGKBSA-N C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 YNXLOPYTAAFMTN-SBUIBGKBSA-N 0.000 title 1
- 101500025005 Homo sapiens Neuropeptide Y Proteins 0.000 title 1
- 102100029909 Peptide YY Human genes 0.000 title 1
- XKWCTHKJQNUFOQ-HRPSIEBRSA-N gtpl1504 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 XKWCTHKJQNUFOQ-HRPSIEBRSA-N 0.000 title 1
- 108091005474 pancreatic polypeptide receptors Proteins 0.000 title 1
- 108010070727 peptide YY receptor Proteins 0.000 title 1
- 102000028435 Neuropeptide Y4 receptor Human genes 0.000 abstract 9
- 108010002245 Neuropeptide Y4 receptor Proteins 0.000 abstract 9
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 239000013598 vector Substances 0.000 abstract 2
- 108020000948 Antisense Oligonucleotides Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 abstract 1
- 239000000074 antisense oligonucleotide Substances 0.000 abstract 1
- 238000012230 antisense oligonucleotides Methods 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000007877 drug screening Methods 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002853 nucleic acid probe Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/176,412 US5516653A (en) | 1993-12-28 | 1993-12-28 | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
PCT/US1994/014436 WO1995017906A1 (en) | 1993-12-28 | 1994-12-28 | Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0746332T3 true DK0746332T3 (da) | 2000-06-13 |
DK0746332T4 DK0746332T4 (da) | 2010-08-16 |
Family
ID=22644257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95907215.8T DK0746332T4 (da) | 1993-12-28 | 1994-12-28 | DNA, som koder for et humant neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelser deraf |
Country Status (11)
Country | Link |
---|---|
US (4) | US5516653A (da) |
EP (1) | EP0746332B2 (da) |
JP (1) | JP4216326B2 (da) |
AT (1) | ATE189607T1 (da) |
AU (1) | AU702438B2 (da) |
CA (1) | CA2156272C (da) |
DE (2) | DE746332T1 (da) |
DK (1) | DK0746332T4 (da) |
ES (1) | ES2097717T5 (da) |
GR (1) | GR970300026T1 (da) |
WO (1) | WO1995017906A1 (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516653A (en) | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
US5545549A (en) * | 1994-02-03 | 1996-08-13 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof |
JPH10508486A (ja) * | 1994-11-07 | 1998-08-25 | メルク エンド カンパニー インコーポレーテッド | 修飾神経ペプチドyレセプター |
US5602024A (en) | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
US5989920A (en) * | 1994-12-02 | 1999-11-23 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5 |
US5965392A (en) | 1996-04-08 | 1999-10-12 | Bayer Corporation | Neuropeptide Y receptor Y5 and nucleic acid sequences |
US5919901A (en) * | 1996-04-08 | 1999-07-06 | Bayer Corporation | Neuropeptide Y receptor Y5 and nucleic acid sequences |
US5908830A (en) * | 1996-10-31 | 1999-06-01 | Merck & Co., Inc. | Combination therapy for the treatment of diabetes and obesity |
US6713265B1 (en) | 1997-06-04 | 2004-03-30 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
US5916869A (en) * | 1997-06-13 | 1999-06-29 | North Carolina State University | Method of treating birds in ovo |
GB2344050A (en) * | 1998-11-26 | 2000-05-31 | Ferring Bv | Agents useful in the treatment of reproductive disorders. |
US7745216B2 (en) | 1999-02-10 | 2010-06-29 | Curis, Inc. | Methods and reagents for treating glucose metabolic disorders |
US6221660B1 (en) | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
WO2001016316A1 (fr) * | 1999-08-27 | 2001-03-08 | Takeda Chemical Industries, Ltd. | Proteine recepteur couplee a une proteine g et adn correspondant |
WO2001053477A1 (en) * | 2000-01-20 | 2001-07-26 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
DE60132924T2 (de) | 2000-10-23 | 2009-03-05 | Gen-Probe Inc., San Diego | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) |
ATE412778T1 (de) * | 2002-05-15 | 2008-11-15 | Integragen Sa | Humanes fettleibigkeit suszeptibilitätsgen und deren verwendungen |
EP1362926A1 (en) * | 2002-05-15 | 2003-11-19 | Integragen | Human obesity susceptibility gene and uses thereof |
EP1403380A1 (en) * | 2002-09-27 | 2004-03-31 | Integragen | Human obesity susceptibility gene and uses thereof |
EP1583549A4 (en) * | 2003-01-17 | 2006-10-04 | Sod Conseils Rech Applic | YY PEPTIDE ANALOGS |
US20070042433A1 (en) * | 2003-03-26 | 2007-02-22 | Jianxin Bao | Neuregulin protein regulation of synaptic proteins |
CA2543999A1 (en) * | 2003-10-30 | 2005-05-12 | Banyu Pharmaceutical Co., Ltd. | Monkey npy y4 receptor and method of evaluating compound |
US20070270339A1 (en) * | 2004-04-23 | 2007-11-22 | Serono, Inc. | Use of GPCR54 Ligands for the Treatment of Infertility |
EP1765083A4 (en) * | 2004-05-28 | 2008-08-20 | Serono Lab | USE OF IL-17 TO TREAT FERTILITY DISORDERS |
PA8660701A1 (es) * | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
WO2006091506A2 (en) * | 2005-02-24 | 2006-08-31 | Bayer Pharmaceuticals Corporation | Neuropeptide y4 receptor agonists |
AU2005337116A1 (en) * | 2005-09-21 | 2007-04-12 | 7Tm Pharma A/S | Y4 selective receptor agonists for therapeutic interventions |
EA200800875A1 (ru) | 2005-09-21 | 2008-08-29 | 7ТиЭм ФАРМА А/С | Рецепторные агонисты, селективные к y2 рецептору, для терапевтического воздействия |
US20070197445A1 (en) * | 2006-01-18 | 2007-08-23 | University Of Cincinnati | Compounds for control of appetite |
EP1990427A4 (en) | 2006-02-24 | 2009-04-29 | Banyu Pharma Co Ltd | NPY Y4-AGONIST AS A THERAPEUTIC AGENT AGAINST A DISEASE ACHIEVED BY A MALFUNCTION OF THE DARMTRACT |
CA2751673A1 (en) * | 2009-02-20 | 2010-08-26 | Ipsen Pharma S.A.S | Analogues of neuropeptide y having proline substitution at position 34 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839343A (en) * | 1987-03-13 | 1989-06-13 | Debiopharm, S.A. | Preparation containing hexatriacontapeptides and methods of use |
US5328899A (en) * | 1988-07-15 | 1994-07-12 | The Salk Institute For Biological Studies | NPY peptide analogs |
US5026685A (en) * | 1988-07-15 | 1991-06-25 | The Salk Institute For Biological Studies | NPY peptide analogs |
GB8818020D0 (en) * | 1988-07-28 | 1988-09-01 | Ici Plc | Method for amplification of nucleotide sequences |
ZA896376B (en) * | 1988-08-26 | 1990-05-30 | Merrell Dow Pharma | Neuropeptide y agonists |
ZA896374B (en) * | 1988-08-26 | 1990-05-30 | Merrell Dow Pharma | Neuropeptide y antagonists |
US5053337A (en) * | 1989-10-30 | 1991-10-01 | Neurogenetic Corporation | DNA encoding an α2B -adrenergic receptor |
DK0448765T3 (da) * | 1990-03-30 | 1994-09-19 | Heumann Pharma Gmbh & Co | Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkning |
SE9002278L (sv) * | 1990-06-28 | 1991-12-29 | Perstorp Ab | Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel |
JPH0463594A (ja) * | 1990-07-03 | 1992-02-28 | Tanpaku Kogaku Kenkyusho:Kk | 成長ホルモンレセプターのホルモン結合領域蛋白の製造法 |
WO1993009227A1 (en) * | 1991-11-06 | 1993-05-13 | Garvan Institute Of Medical Research | Human neuropeptide y-y1 receptor |
WO1993024515A1 (en) * | 1992-05-29 | 1993-12-09 | Cornell Research Foundation, Inc. | Human neuropeptide y/peptide yy receptor of the y1-type and antisense oligonucleotides thereto which inhibit vasoconstriction |
GB9213215D0 (en) * | 1992-06-20 | 1992-08-05 | Wellcome Found | Peptides |
JPH06116284A (ja) * | 1992-10-02 | 1994-04-26 | Yamanouchi Pharmaceut Co Ltd | 新規ペプチド |
FR2701480B1 (fr) * | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
JPH08510205A (ja) * | 1993-03-29 | 1996-10-29 | ユニバーシティ オブ シンシナティ | Yyペプチドのアナログとその用途 |
AU7174494A (en) * | 1993-06-18 | 1995-01-17 | University Of Cincinnati, The | Neuropeptide y antagonists and agonists |
US5516653A (en) | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
CA2134428A1 (en) * | 1994-10-26 | 1996-04-27 | Albert Tseng | Neuropeptide y y2 agonist peptides |
JPH10508486A (ja) * | 1994-11-07 | 1998-08-25 | メルク エンド カンパニー インコーポレーテッド | 修飾神経ペプチドyレセプター |
US5602024A (en) * | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
US5621079A (en) * | 1995-02-03 | 1997-04-15 | Merck & Co., Inc. | Neuropeptide Y receptor |
AUPN646795A0 (en) * | 1995-11-09 | 1995-11-30 | Garvan Institute Of Medical Research | Neuropeptide Y-Y5 receptor |
US5965392A (en) * | 1996-04-08 | 1999-10-12 | Bayer Corporation | Neuropeptide Y receptor Y5 and nucleic acid sequences |
US6355478B1 (en) * | 1996-06-17 | 2002-03-12 | Eli Lilly And Company | Rhesus monkey neuropeptide Y Y2 receptor |
-
1993
- 1993-12-28 US US08/176,412 patent/US5516653A/en not_active Expired - Lifetime
-
1994
- 1994-12-28 ES ES95907215T patent/ES2097717T5/es not_active Expired - Lifetime
- 1994-12-28 EP EP95907215A patent/EP0746332B2/en not_active Expired - Lifetime
- 1994-12-28 DE DE0746332T patent/DE746332T1/de active Pending
- 1994-12-28 DE DE69423007T patent/DE69423007T3/de not_active Expired - Lifetime
- 1994-12-28 CA CA002156272A patent/CA2156272C/en not_active Expired - Lifetime
- 1994-12-28 DK DK95907215.8T patent/DK0746332T4/da active
- 1994-12-28 AU AU15518/95A patent/AU702438B2/en not_active Expired
- 1994-12-28 US US08/495,695 patent/US5976814A/en not_active Expired - Lifetime
- 1994-12-28 WO PCT/US1994/014436 patent/WO1995017906A1/en active IP Right Grant
- 1994-12-28 JP JP51808295A patent/JP4216326B2/ja not_active Expired - Lifetime
- 1994-12-28 AT AT95907215T patent/ATE189607T1/de active
-
1995
- 1995-11-08 US US08/555,268 patent/US5958709A/en not_active Expired - Lifetime
-
1997
- 1997-09-30 GR GR970300026T patent/GR970300026T1/el unknown
-
1999
- 1999-10-29 US US09/430,775 patent/US6913892B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5958709A (en) | 1999-09-28 |
US5516653A (en) | 1996-05-14 |
DE69423007T3 (de) | 2011-02-10 |
EP0746332B2 (en) | 2010-05-19 |
DE69423007D1 (de) | 2000-03-16 |
US5976814A (en) | 1999-11-02 |
EP0746332A4 (en) | 1997-02-26 |
WO1995017906A1 (en) | 1995-07-06 |
CA2156272C (en) | 2009-09-15 |
ATE189607T1 (de) | 2000-02-15 |
EP0746332A1 (en) | 1996-12-11 |
AU1551895A (en) | 1995-07-17 |
CA2156272A1 (en) | 1995-07-06 |
ES2097717T1 (es) | 1997-04-16 |
ES2097717T5 (es) | 2010-10-18 |
DK0746332T4 (da) | 2010-08-16 |
ES2097717T3 (es) | 2000-06-16 |
AU702438B2 (en) | 1999-02-18 |
US6913892B1 (en) | 2005-07-05 |
DE69423007T2 (de) | 2000-10-19 |
DE746332T1 (de) | 1997-04-10 |
JPH09511127A (ja) | 1997-11-11 |
JP4216326B2 (ja) | 2009-01-28 |
EP0746332B1 (en) | 2000-02-09 |
GR970300026T1 (en) | 1997-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0746332T3 (da) | DNA, som koder for en human neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelse deraf | |
ES2083344T1 (es) | Dna que codifica un receptor 5-ht1f humano y utilizacion del mismo. | |
FI925034A0 (fi) | Dna som kodar maenniskans 5-ht1d-receptorer och deras anvaendning | |
WO1994014957A3 (en) | Dna encoding 5-ht4 serotonin receptors and uses thereof | |
ES2173922T3 (es) | Polipeptidos de la familia del gen de la semaforina. | |
NO20020861D0 (no) | PD-1, en reseptor for B7-4, og anvendelser derav | |
GR960300015T1 (da) | ||
CA2127117A1 (en) | DNA Encoding a Human Serotonin Receptor (5-HT4B) and Uses Thereof | |
EP0538395A4 (en) | Nucleic acid sequences encoding a human dopamine d 1? receptor | |
DE69417223T2 (de) | Ein menschlicher t-zell rezeptor der protein g-gekoppelte rezeptor familie | |
MXPA02000293A (es) | Isoformas de la amp ciclico fosfodiesterasa y metodos de uso. | |
Gerald et al. | DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof | |
WO2003087331A3 (en) | Polyvalent cation-sensing receptor in atlantic salmon |